These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11869699)

  • 21. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
    Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
    J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
    Kam PC; Thompson JF
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.
    Bartlett DL; Ma G; Alexander HR; Libutti SK; Fraker DL
    Cancer; 1997 Dec; 80(11):2084-90. PubMed ID: 9392330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
    Guadagni S; Fiorentini G; Clementi M; Palumbo G; Palumbo P; Chiominto A; Baldoni S; Masedu F; Valenti M; Tommaso AD; Fabi B; Aliberti C; Sarti D; Guadagni V; Pellegrini C
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum.
    Wanebo HJ; DiSiena M; Begossi G; Belliveau J; Gustafson E
    Ann Surg Oncol; 2008 Apr; 15(4):1107-16. PubMed ID: 18157578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique.
    Wanebo HJ; Chung MA; Levy AI; Turk PS; Vezeridis MP; Belliveau JF
    Ann Surg Oncol; 1996 May; 3(3):295-303. PubMed ID: 8726186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
    Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
    Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study.
    Guadagni S; Clementi M; Bencivenga M; Kusamura S; Fiorentini C; Masedu F
    Updates Surg; 2018 Dec; 70(4):441-447. PubMed ID: 30191532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperthermic pelvic perfusion with tumor necrosis factor-α for locally advanced cancers: encouraging results of a phase II study.
    Bonvalot S; de Baere T; Mendiboure J; Paci A; Farace F; Drouard-Troalen L; Bonnet L; Hakime A; Bonniaud G; Raynard B; Israel P; Le Cesne A; Eggermont AM; Laplanche A; Muret J
    Ann Surg; 2012 Feb; 255(2):281-6. PubMed ID: 22241290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy monitoring of regional chemotherapy by magnetic resonance spectroscopy].
    Semmler W; Bachert-Baumann P; Schlag P; Gückel F; Lorenz WJ; Van Kaick G
    Z Gastroenterol Verh; 1989 Jul; 24():202-3. PubMed ID: 2474953
    [No Abstract]   [Full Text] [Related]  

  • 36. Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb.
    Rauschecker HF; Foth H; Michaelis HC; Horst F; Gatzemeier W; Willenbrock C; Voth E; Kahl GF
    Cancer Chemother Pharmacol; 1991; 27(5):379-84. PubMed ID: 1998997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
    Fletcher WS; Woltering EA; Moseley HS; Bos G; Lebredo L; Brown D; Small K
    Cancer Treat Res; 1993; 62():241-4. PubMed ID: 8096739
    [No Abstract]   [Full Text] [Related]  

  • 38. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma.
    Buzaid A; Legha SS; Balch CM; Ross M; Ring S; Plager C; Papadopoulos NE; el-Naggar AK; Benjamin RS
    Cancer; 1994 Nov; 74(9):2476-82. PubMed ID: 7923003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
    Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
    Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.